| Type 2 Diabetes Mellitus |
1 |
1 |
| SGLT2 Inhibitor |
0 |
0.99 |
| Cardiovascular Risk Management |
0 |
0.52 |
| Coronary Artery Disease (CAD) |
0 |
0.38 |
| Heart Failure (HF) |
0 |
0.35 |
| Hypertension |
0 |
0.31 |
| Heart |
0 |
0.27 |
| Infarction |
0 |
0.27 |
| Myocardial Infarction (MI) |
0 |
0.27 |
| Hemoglobin A1c |
0 |
0.19 |
| Renal Disease |
0 |
0.19 |
| Chronic Kidney Disease |
0 |
0.18 |
| Renal Failure |
0 |
0.18 |
| Cardiovascular disease |
0 |
0.13 |
| Cyclooxygenase (COX) |
0 |
0.13 |
| Hemoglobin |
0 |
0.13 |
| Kidney |
0 |
0.13 |
| Meta-Analysis |
0 |
0.13 |
| Prognosis |
0 |
0.13 |
| Receptors |
0 |
0.13 |
| UK Site Content |
0 |
0.13 |